Disease-specific induced pluripotent stem cells

A platform for human disease modeling and drug discovery

Jiho Jang, Jeong Eun Yoo, Jeong Ah Lee, Dongjin R. Lee, Ji Young Kim, Yong Jun Huh, Dae-Sung Kim, Chul Yong Park, Dong Youn Hwang, Han Soo Kim, Hoon Chul Kang, Dong Wook Kim

Research output: Contribution to journalArticle

56 Citations (Scopus)

Abstract

The generation of disease-specific induced pluripotent stem cell (iPSC) lines from patients with incurable diseases is a promising approach for studying disease mechanisms and drug screening. Such innovation enables to obtain autologous cell sources in regenerative medicine. Herein, we report the generation and characterization of iPSCs from fibroblasts of patients with sporadic or familial diseases, including Parkinson's disease (PD), Alzheimer's disease (AD), juvenile-onset, type I diabetes mellitus (JDM), and Duchenne type muscular dystrophy (DMD), as well as from normal human fibroblasts (WT). As an example to modeling disease using disease-specific iPSCs, we also discuss the previously established childhood cerebral adrenoleukodystrophy (CCALD)- and adrenomyeloneuropathy (AMN)-iPSCs by our group. Through DNA fingerprinting analysis, the origins of generated disease-specific iPSC lines were identified. Each iPSC line exhibited an intense alkaline phosphatase activity, expression of pluripotent markers, and the potential to differentiate into all three embryonic germ layers: the ectoderm, endoderm, and mesoderm. Expression of endogenous pluripotent markers and downregulation of retrovirus-delivered transgenes [OCT4 (POU5F1), SOX2, KLF4, and c-MYC] were observed in the generated iPSCs. Collectively, our results demonstrated that disease-specific iPSC lines characteristically resembled hESC lines. Furthermore, we were able to differentiate PD-iPSCs, one of the disease-specific-iPSC lines we generated, into dopaminergic (DA) neurons, the cell type mostly affected by PD. These PD-specific DA neurons along with other examples of cell models derived from disease-specific iPSCs would provide a powerful platform for examining the pathophysiology of relevant diseases at the cellular and molecular levels and for developing new drugs and therapeutic regimens.

Original languageEnglish
Pages (from-to)202-213
Number of pages12
JournalExperimental and Molecular Medicine
Volume44
Issue number3
DOIs
Publication statusPublished - 2012 Jan 1
Externally publishedYes

Fingerprint

Induced Pluripotent Stem Cells
Drug Discovery
Stem cells
Parkinson Disease
Cell Line
Adrenoleukodystrophy
Dopaminergic Neurons
Type 1 Diabetes Mellitus
Fibroblasts
Germ Layers
Neurons
Endoderm
Ectoderm
Preclinical Drug Evaluations
Regenerative Medicine
DNA Fingerprinting
Duchenne Muscular Dystrophy
Mesoderm
Retroviridae
Transgenes

Keywords

  • Biological
  • Drug evaluation
  • Drug screening
  • Induced pluripotent stem cells
  • Models
  • Preclinical
  • Tissue therapy

ASJC Scopus subject areas

  • Biochemistry
  • Molecular Medicine
  • Molecular Biology
  • Clinical Biochemistry

Cite this

Disease-specific induced pluripotent stem cells : A platform for human disease modeling and drug discovery. / Jang, Jiho; Yoo, Jeong Eun; Lee, Jeong Ah; Lee, Dongjin R.; Kim, Ji Young; Huh, Yong Jun; Kim, Dae-Sung; Park, Chul Yong; Hwang, Dong Youn; Kim, Han Soo; Kang, Hoon Chul; Kim, Dong Wook.

In: Experimental and Molecular Medicine, Vol. 44, No. 3, 01.01.2012, p. 202-213.

Research output: Contribution to journalArticle

Jang, J, Yoo, JE, Lee, JA, Lee, DR, Kim, JY, Huh, YJ, Kim, D-S, Park, CY, Hwang, DY, Kim, HS, Kang, HC & Kim, DW 2012, 'Disease-specific induced pluripotent stem cells: A platform for human disease modeling and drug discovery', Experimental and Molecular Medicine, vol. 44, no. 3, pp. 202-213. https://doi.org/10.3858/emm.2012.44.3.015
Jang, Jiho ; Yoo, Jeong Eun ; Lee, Jeong Ah ; Lee, Dongjin R. ; Kim, Ji Young ; Huh, Yong Jun ; Kim, Dae-Sung ; Park, Chul Yong ; Hwang, Dong Youn ; Kim, Han Soo ; Kang, Hoon Chul ; Kim, Dong Wook. / Disease-specific induced pluripotent stem cells : A platform for human disease modeling and drug discovery. In: Experimental and Molecular Medicine. 2012 ; Vol. 44, No. 3. pp. 202-213.
@article{7d3313b5314a43349bd5001ac0aca30d,
title = "Disease-specific induced pluripotent stem cells: A platform for human disease modeling and drug discovery",
abstract = "The generation of disease-specific induced pluripotent stem cell (iPSC) lines from patients with incurable diseases is a promising approach for studying disease mechanisms and drug screening. Such innovation enables to obtain autologous cell sources in regenerative medicine. Herein, we report the generation and characterization of iPSCs from fibroblasts of patients with sporadic or familial diseases, including Parkinson's disease (PD), Alzheimer's disease (AD), juvenile-onset, type I diabetes mellitus (JDM), and Duchenne type muscular dystrophy (DMD), as well as from normal human fibroblasts (WT). As an example to modeling disease using disease-specific iPSCs, we also discuss the previously established childhood cerebral adrenoleukodystrophy (CCALD)- and adrenomyeloneuropathy (AMN)-iPSCs by our group. Through DNA fingerprinting analysis, the origins of generated disease-specific iPSC lines were identified. Each iPSC line exhibited an intense alkaline phosphatase activity, expression of pluripotent markers, and the potential to differentiate into all three embryonic germ layers: the ectoderm, endoderm, and mesoderm. Expression of endogenous pluripotent markers and downregulation of retrovirus-delivered transgenes [OCT4 (POU5F1), SOX2, KLF4, and c-MYC] were observed in the generated iPSCs. Collectively, our results demonstrated that disease-specific iPSC lines characteristically resembled hESC lines. Furthermore, we were able to differentiate PD-iPSCs, one of the disease-specific-iPSC lines we generated, into dopaminergic (DA) neurons, the cell type mostly affected by PD. These PD-specific DA neurons along with other examples of cell models derived from disease-specific iPSCs would provide a powerful platform for examining the pathophysiology of relevant diseases at the cellular and molecular levels and for developing new drugs and therapeutic regimens.",
keywords = "Biological, Drug evaluation, Drug screening, Induced pluripotent stem cells, Models, Preclinical, Tissue therapy",
author = "Jiho Jang and Yoo, {Jeong Eun} and Lee, {Jeong Ah} and Lee, {Dongjin R.} and Kim, {Ji Young} and Huh, {Yong Jun} and Dae-Sung Kim and Park, {Chul Yong} and Hwang, {Dong Youn} and Kim, {Han Soo} and Kang, {Hoon Chul} and Kim, {Dong Wook}",
year = "2012",
month = "1",
day = "1",
doi = "10.3858/emm.2012.44.3.015",
language = "English",
volume = "44",
pages = "202--213",
journal = "Experimental and Molecular Medicine",
issn = "1226-3613",
publisher = "Korean Society of Med. Biochemistry and Mol. Biology",
number = "3",

}

TY - JOUR

T1 - Disease-specific induced pluripotent stem cells

T2 - A platform for human disease modeling and drug discovery

AU - Jang, Jiho

AU - Yoo, Jeong Eun

AU - Lee, Jeong Ah

AU - Lee, Dongjin R.

AU - Kim, Ji Young

AU - Huh, Yong Jun

AU - Kim, Dae-Sung

AU - Park, Chul Yong

AU - Hwang, Dong Youn

AU - Kim, Han Soo

AU - Kang, Hoon Chul

AU - Kim, Dong Wook

PY - 2012/1/1

Y1 - 2012/1/1

N2 - The generation of disease-specific induced pluripotent stem cell (iPSC) lines from patients with incurable diseases is a promising approach for studying disease mechanisms and drug screening. Such innovation enables to obtain autologous cell sources in regenerative medicine. Herein, we report the generation and characterization of iPSCs from fibroblasts of patients with sporadic or familial diseases, including Parkinson's disease (PD), Alzheimer's disease (AD), juvenile-onset, type I diabetes mellitus (JDM), and Duchenne type muscular dystrophy (DMD), as well as from normal human fibroblasts (WT). As an example to modeling disease using disease-specific iPSCs, we also discuss the previously established childhood cerebral adrenoleukodystrophy (CCALD)- and adrenomyeloneuropathy (AMN)-iPSCs by our group. Through DNA fingerprinting analysis, the origins of generated disease-specific iPSC lines were identified. Each iPSC line exhibited an intense alkaline phosphatase activity, expression of pluripotent markers, and the potential to differentiate into all three embryonic germ layers: the ectoderm, endoderm, and mesoderm. Expression of endogenous pluripotent markers and downregulation of retrovirus-delivered transgenes [OCT4 (POU5F1), SOX2, KLF4, and c-MYC] were observed in the generated iPSCs. Collectively, our results demonstrated that disease-specific iPSC lines characteristically resembled hESC lines. Furthermore, we were able to differentiate PD-iPSCs, one of the disease-specific-iPSC lines we generated, into dopaminergic (DA) neurons, the cell type mostly affected by PD. These PD-specific DA neurons along with other examples of cell models derived from disease-specific iPSCs would provide a powerful platform for examining the pathophysiology of relevant diseases at the cellular and molecular levels and for developing new drugs and therapeutic regimens.

AB - The generation of disease-specific induced pluripotent stem cell (iPSC) lines from patients with incurable diseases is a promising approach for studying disease mechanisms and drug screening. Such innovation enables to obtain autologous cell sources in regenerative medicine. Herein, we report the generation and characterization of iPSCs from fibroblasts of patients with sporadic or familial diseases, including Parkinson's disease (PD), Alzheimer's disease (AD), juvenile-onset, type I diabetes mellitus (JDM), and Duchenne type muscular dystrophy (DMD), as well as from normal human fibroblasts (WT). As an example to modeling disease using disease-specific iPSCs, we also discuss the previously established childhood cerebral adrenoleukodystrophy (CCALD)- and adrenomyeloneuropathy (AMN)-iPSCs by our group. Through DNA fingerprinting analysis, the origins of generated disease-specific iPSC lines were identified. Each iPSC line exhibited an intense alkaline phosphatase activity, expression of pluripotent markers, and the potential to differentiate into all three embryonic germ layers: the ectoderm, endoderm, and mesoderm. Expression of endogenous pluripotent markers and downregulation of retrovirus-delivered transgenes [OCT4 (POU5F1), SOX2, KLF4, and c-MYC] were observed in the generated iPSCs. Collectively, our results demonstrated that disease-specific iPSC lines characteristically resembled hESC lines. Furthermore, we were able to differentiate PD-iPSCs, one of the disease-specific-iPSC lines we generated, into dopaminergic (DA) neurons, the cell type mostly affected by PD. These PD-specific DA neurons along with other examples of cell models derived from disease-specific iPSCs would provide a powerful platform for examining the pathophysiology of relevant diseases at the cellular and molecular levels and for developing new drugs and therapeutic regimens.

KW - Biological

KW - Drug evaluation

KW - Drug screening

KW - Induced pluripotent stem cells

KW - Models

KW - Preclinical

KW - Tissue therapy

UR - http://www.scopus.com/inward/record.url?scp=84859781307&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84859781307&partnerID=8YFLogxK

U2 - 10.3858/emm.2012.44.3.015

DO - 10.3858/emm.2012.44.3.015

M3 - Article

VL - 44

SP - 202

EP - 213

JO - Experimental and Molecular Medicine

JF - Experimental and Molecular Medicine

SN - 1226-3613

IS - 3

ER -